Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXEL | Common Stock | Options Exercise | $114K | +60K | +15.41% | $1.90* | 449K | Jun 17, 2021 | Direct | F1 |
transaction | EXEL | Common Stock | Sale | -$1.33M | -60K | -13.35% | $22.18 | 389K | Jun 17, 2021 | Direct | F2, F3 |
holding | EXEL | Common Stock | 17.1K | Jun 17, 2021 | By 401(k) | F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXEL | Option (right to buy) | Options Exercise | $0 | -60K | -34.29% | $0.00 | 115K | Jun 17, 2021 | Common Stock | 60K | $1.90 | Direct | F5 |
Id | Content |
---|---|
F1 | Includes 215,102 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
F2 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2021. |
F3 | Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.90 to $22.40. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. |
F4 | Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of June 16, 2021. |
F5 | The option, representing the right to purchase a total of 175,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. |